TB-500 (Thymosin Beta-4 synthetic) is the most systemic healing peptide available for research — unlike BPC-157 which works best with localized administration, TB-500 distributes throughout the body from any injection site and simultaneously promotes healing across multiple tissues. This makes it especially valuable for multi-site injuries, systemic recovery, and cardiac or neural damage.
Loading vs Maintenance Protocol
TB-500 is unique among healing peptides in using a distinct loading/maintenance structure:
Loading Phase (Weeks 1-4 to 1-6):
- Dose: 5mg subcutaneous injection, twice per week (10mg/week total)
- Purpose: Saturate tissues with Thymosin Beta-4 to initiate the systemic healing cascade
- Timeline: Most researchers report noticeable recovery improvements beginning at week 2-3
Maintenance Phase (Week 5+):
- Dose: 2.5-5mg subcutaneous injection, once or twice per week
- Purpose: Sustain tissue saturation and ongoing repair at lower cost
Total protocol length: 8-12 weeks for acute injuries; 3-6 months for chronic conditions or systemic anti-aging applications
Administration: Where and How to Inject
Unlike BPC-157, TB-500's injection site doesn't matter for efficacy. Thymosin Beta-4's mechanism (actin cytoskeleton modulation) operates at the cellular level throughout all tissue types. A single SubQ injection in the abdomen reaches healing cells in the shoulder, knee, or any other target tissue.
Reconstitution: A 5mg vial + 1mL bacteriostatic water = 5mg/mL. For a 5mg dose, draw the entire vial. For a 2.5mg dose, draw 0.5mL (50 units on a U-100 syringe).
Injection site options: Abdomen, thigh, or upper arm SubQ. Rotate between sites to prevent tissue buildup.
Can TB-500 be combined in the same syringe as BPC-157? Yes — both use bacteriostatic water for reconstitution and are compatible in the same injection. This is the standard for the BPC-157 + TB-500 stack.
What Makes TB-500 Unique vs Other Healing Peptides
Systemic reach: The most important differentiator. BPC-157 works most effectively near the injection site; TB-500 works equally well regardless of where it's injected. For multiple injury sites or full-body recovery, TB-500 is superior.
Stem cell mobilization: TB-500 is the only healing peptide with documented ability to mobilize endothelial progenitor cells and mesenchymal stem cells from bone marrow to peripheral injury sites. These stem cells provide the raw material for more complete long-term tissue regeneration.
Cardiac tissue healing: The strongest evidence for any healing peptide in cardiac repair belongs to Thymosin Beta-4. Multiple studies using heart attack models showed significant reduction in infarct size, improved ejection fraction, and promotion of new cardiac vessel formation.
Neural repair: Studies show protection against dopaminergic neurotoxicity and axonal regeneration after peripheral nerve injury.
Stacking with BPC-157
The BPC-157 + TB-500 combination is the most used healing stack in the research community. The two peptides complement rather than duplicate each other:
BPC-157 contributes: Localized tendon/ligament repair (strongest), gut healing, VEGFR2-driven angiogenesis at injury site, oral bioavailability for gut applications
TB-500 contributes: Systemic anti-inflammation, stem cell mobilization, cardiac protection, neural repair, longer-lasting tissue saturation from 2-3 day half-life
Combined loading protocol:
- BPC-157: 500mcg/day SubQ (near injury if possible)
- TB-500: 5mg SubQ 2x/week
Combined maintenance:
- BPC-157: 250mcg/day SubQ
- TB-500: 2.5mg SubQ 2x/week
Key Takeaways
TB-500 is most valuable when systemic recovery is the goal — multiple injury sites, cardiac support, neural healing, or full-body anti-inflammatory protocols. Its loading/maintenance structure and long half-life make it different from BPC-157, and the combination of both covers essentially the full spectrum of soft tissue healing.